pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
MEMPD-205
Parkinson's Disease
GB Sciences Inc
0 catalysts
Preclinical
MEMPD-361
Parkinson's Disease
GB Sciences Inc
0 catalysts
Phase 1
MEN-2312
Hematological Tumor
Stemline Therapeutics Inc
0 catalysts
Phase 1
MEN-2501
Fallopian Tube Cancer
← prev
page 123 of 271
next →
131
Pain89
Neurology1
Stemline Therapeutics Inc
0 catalysts
MEPERGAN
MEPERGAN (MEPERIDINE HYDROCHLORIDE)
Hikma Pharmaceuticals Plc
0 catalysts
Marketed
MEPRON
MEPRON (ATOVAQUONE)
Pneumocystis Pneumonia (Pneumocystosis/Pneumocystis jiroveci Pneumonia)
GlaxoSmithKline LLC
0 catalysts
Preclinical
MER-101
Ewing Sarcoma
MERLIN Biotech LLC
0 catalysts
Phase 2
MET-224o
Obesity
Metsera Inc
0 catalysts
Phase 2
MET-233i
Obesity
Metsera Inc
0 catalysts
Preclinical
MET-X
Urinary Tract Infections
Infex Therapeutics Ltd
0 catalysts
Preclinical
META-001PH
Primary Hyperoxaluria
META Pharmaceuticals Inc
0 catalysts
Marketed
METHADOSE
METHADOSE (METHADONE HYDROCHLORIDE)
Opium (Opioid) Addiction
Mallinckrodt LLC
0 catalysts
METHAMPHETAMINE HYDROCHLORIDE
METHAMPHETAMINE HYDROCHLORIDE (METHAMPHETAMINE HYDROCHLORIDE)
HIKMA
0 catalysts
Phase 2
METHOTREXATE
METHOTREXATE (METHOTREXATE)
Retinitis Pigmentosa (Retinitis)
Dihydrofolate reductase
$ALDXAldeyra Therapeutics, Inc.
0 catalysts
METHOTREXATE SODIUM
METHOTREXATE SODIUM (METHOTREXATE SODIUM)
Alembic Pharmaceuticals Inc
0 catalysts
Marketed
METHYLPREDNISOLONE
METHYLPREDNISOLONE (METHYLPREDNISOLONE)
Acquired (Autoimmune) Hemolytic Anemia
GeneYork Pharmaceuticals Group LLC
0 catalysts
METOCLOPRAMIDE
METOCLOPRAMIDE (METOCLOPRAMIDE)
HOSPIRA
0 catalysts
METOPIRONE
METOPIRONE (METYRAPONE)
ESTEVE
0 catalysts
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE)
SENORES PHARMS
0 catalysts
METRONIDAZOLE VAGINAL GEL
METRONIDAZOLE VAGINAL GEL (METRONIDAZOLE VAGINAL GEL, 1.3 %)
ENCUBE
0 catalysts
Phase 1
MF-300
Sarcopenia
Epirium Bio Inc
0 catalysts
Phase 1
MGC-028
Bile Duct Cancer (Cholangiocarcinoma)
$MGNXMACROGENICS INC
0 catalysts
Preclinical
MGC-030
Solid Tumor
$MGNXMACROGENICS INC
0 catalysts
Phase 2
MGD-014
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$MGNXMACROGENICS INC
0 catalysts
Phase 1
MGD-024
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$MGNXMACROGENICS INC
0 catalysts
Phase 3
MH-002
Ulcerative Colitis
MRM Health NV
0 catalysts
Phase 2
MHB-018A
Graves' Ophthalmopathy
Minghui Pharmaceutical (Shanghai) Co Ltd
0 catalysts
MICROGESTIN 24 FE
MICROGESTIN 24 FE (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)
NOVAST LABS
0 catalysts
MIDAZOLAM IN 0.8% SODIUM CHLORIDE
MIDAZOLAM IN 0.8% SODIUM CHLORIDE (MIDAZOLAM IN 0.8% SODIUM CHLORIDE)
B BRAUN MEDICAL
0 catalysts
Preclinical
MIGRA-NP01
Pancreatic Cancer
Migra-Therapeutics LLC
0 catalysts